Back to Evidence Hub
Case Study S016
2018 Release

Inan 2018: Assessing Clinical Status of HF

Omer T. Inan et al.
Access Paper

Quick Conclusion: S016 is a vital clinical validation for OpenSCG’s heart failure monitoring use case. By proving that SCG can track the clinical improvement from hospital admission to discharge, it establishes SCG as a sensitive 'digital biomarker' for hemodynamic congestion and recovery, potentially more sensitive than heart rate alone.

📊 Key Accuracy Metrics

MetricResult
GSS Decompensated HF44.4 ± 4.9
GSS Compensated HF35.2 ± 10.5
P-value (Comp vs Decomp)< 0.001
GSS Admission to Discharge (N=6)44 ± 4.1 to 35 ± 3.9 (P < 0.05)

🔍 Study Analysis

Objective & Population

Observational Study with Longitudinal follow-up. Cohort: Heart failure patients (Compensated N=32, Decompensated N=13) (N=45).

What it Supports

The study supports using wearable SCG sensors to assess the physiological 'cardiovascular reserve' of heart failure patients. It demonstrates that spectral changes in SCG after a submaximal exercise challenge (6MWT) can objectively distinguish between compensated (stable) and decompensated (worsening) HF states.

What it Does Not Support

The study does not support the use of SCG for heart failure diagnosis without an exercise challenge (at rest). It also does not yet provide a fully automated 'red-flag' system ready for consumer use without medical oversight.

🛠 Technical Context

Featured Illustration

Figure 1. Seismocardiogram (SCG) and ECG sensing patch. A, The SCG signal represents the vibrations of the chest wall in response to the movement of the heart and blood with each heartbeat. SCG is measured using a miniature, 3-axis accelerometer, typically positioned on the midsternum. B, The SCG signal consists of vibrations in 3 axes: head-to-foot, dorso-ventral, and lateral. C, A custom, small, wearable patch for measuring SCG and ECG signals was designed. The patch is placed on the chest using 3 gel adhesive electrodes and stores data locally on a micro secure digital card. The low power design allows for >50 h of continuous recording and use without recharging the battery.

Figure 1. Seismocardiogram (SCG) and ECG sensing patch. A, The SCG signal represents the vibrations of the chest wall in response to the movement of the heart and blood with each heartbeat. SCG is measured using a miniature, 3-axis accelerometer, typically positioned on the midsternum. B, The SCG signal consists of vibrations in 3 axes: head-to-foot, dorso-ventral, and lateral. C, A custom, small, wearable patch for measuring SCG and ECG signals was designed. The patch is placed on the chest using 3 gel adhesive electrodes and stores data locally on a micro secure digital card. The low power design allows for >50 h of continuous recording and use without recharging the battery.

Study Snapshot

Metadata Summary

Target Population

Heart failure patients (Compensated N=32, Decompensated N=13)

N

Sample Size

45 Subjects

Validated Metric

44.4 ± 4.9

Critical Appraisal
supporting

“Validated the use of SCG graph similarity to differentiate between compensated and decompensated heart failure states.”